Florence Brunet-Possenti

19PUBLICATIONS
49CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersRadiation therapyMolecular targetsCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Nov 24, 2025
Benefit of immune checkpoint inhibitors as adjuvant treatment for acral melanomas.

Damien Sanogo, Romain Levard, Julie Cassecuel

|Jul 14, 2025
Neoadjuvant immune checkpoint inhibitors for patients with resectable stage III/IV melanoma: a nationwide real-life study in France (NEOMEL).

Charlée Nardin, Charlotte Cavalieri, Céleste Lebbé

|Jun 27, 2025
Detection of alpha-human papillomavirus types in cutaneous squamous cell carcinoma associated with markers of carcinogenesis: a retrospective study.

Florence Brunet-Possenti, Morgane Weiss, Jean-Luc Prétet

|Nov 28, 2024
The efficacy and safety of first-line metastatic melanoma treatment with ipilimumab + nivolumab vs. nivolumab in a real-world setting.

Karine Billard, Laurent Mortier, Olivier Dereure

|Jun 12, 2024
Radiotherapy and prognostic factors in adnexal carcinomas: A retrospective study of 657 patients from the French CARADERM network.

Robin Zagala, Stephane Dalle, Marie Beylot-Barry

|May 18, 2024
Molecularly matched targeted therapy: a promising approach for refractory metastatic melanoma.

Emily Connell, Émilie Gerard, Bénédicte Oules

Pageof 4

Frequent Collaborators

5 joint publications

Julia Sanchez

3 joint publications

Olivier Dereure

3 joint publications

Thierry Lesimple

2 joint publications

Brigitte Dreno